Quyết định 5785/QD-BYT

DECISION

INTERIM GUIDELINES ON COVID-19 IMMUNIZATION SCREENING FOR PEOPLE AGED 18 OR MORE

THE MINISTER OF HEALTH

Pursuant to Government's Decree No. 75/2017/ND-CP dated June 20, 2017 on functions, tasks, powers and organizational structure of the Ministry of Health;

Pursuant to Resolution No. 86/NQ-CP dated August 6, 2021 of the Government on urgent solutions for COVID-19 prevention and control to implement Resolution NO. 30/2021/QH15 dated July 28, 2021 of the 15th National Assembly;

At the request of the Specialized Council for development of guidelines for COVID-19 immunization screening;

At request of Director General of Vietnam Administration of Medical Services.

HEREBY DECIDES:

Article 1. The “Interim guidelines on COVID-19 immunization screening for people aged 18 or more” are attached hereto.

Article 2. The “Interim guidelines on COVID-19 immunization screening for people aged 18 or more” apply to all public and private medical examination and treatment establishments and immunization facilities nationwide.

Article 3. This Decision comes into effect from the day of signing. Annul Decision No. 4355/QD-BYT dated September 10, 2021 of Minister of Health on Interim guidelines on COVID-19 immunization screening.

Article 4. Director of Department of Medical Examination and Treatment, Chief of the Ministry Office, Chief Ministry Inspector, directors of departments and agencies affiliated to Ministry of Health; directors of medical establishments affiliated to Ministry of Health; Directors of Departments of Health of provinces and central-affiliated cities, heads of relevant entities; heads of medical sector of ministries are responsible for implementation of this Decision./.

INTERIM GUIDANCE

INTERIM GUIDELINES ON COVID-19 IMMUNIZATION SCREENING FOR PEOPLE AGED 18 OR MORE
(Attached to Decision No. 5785/QD-BYT dated December 21, 2021)

I. Purpose of screening

Detect and classify individuals eligible for COVID-19 immunization to ensure safety.

II. Immunization beneficiary classification

1. Individuals eligible for immunization

Individuals within the age for immunization as per recommendation under use instruction of manufacturers and not too sensitive to active ingredients or any excipients of the vaccine.

2. Individuals that require attention in immunization

The following individuals must be screened carefully and thoroughly:

- Individuals who previously had allergic reactions to other allergens.

- Individuals who have underlying medical conditions or chronic diseases.

- Individuals who have lost their senses or behavioral capacity.

- Individuals who used to suffer from thrombocytopenia and/or coagulation disorders.

- Pregnant women ≥ 13 weeks.

- Individuals having irregular vital signs:

+ Temperature < 35,5^oC and > 37,5^oC.

+ Pulse: < 60 times/minute or > 100 times/minute.

+ Minimum blood pressure < 60 mmHg or > 90 mmHg and/or maximum blood pressure < 90 mmHg or > 140 mmHg or 30 mmHg more than daily blood pressure (for individuals with hypertension receiving treatment and having medical records).

+ Respiratory rate > 25 times/minute.

3. Individuals whose immunization must be delayed

- Having chronic diseases.

- Pregnant women < 13 weeks.

4. Contraindications

- Previously having allergic reactions with the same COVID-19 vaccine.

- Having any contraindication as per publication of manufacturers.

III. Immunization screening

1. Asking about medical history

1.1. Current health conditions

Examine health for fever, any chronic disease, and any acute disease that are in progress, especially if the conditions suggest COVID-19.

1.2. History of COVID-19 immunization

Request information about the type of COVID-19 vaccine and time of vaccination.

1.3. History of allergic reactions

- Previously had allergic reactions to any allergen.

- Have history of severe allergic reactions, including anaphylaxis.

- Have history of allergic reactions with vaccine or any component of vaccine.

1.4. History of COVID-19 infection.

1.5. History of severe immunodeficiency, terminal cancer, receiving chemotherapy or radiotherapy.

1.6. History of coagulation disorders/hemostasis disorders or currently taking anticoagulant drugs.

1.7. Pregnant women (if any) or breastfeeding women:

- Pregnant women: Inquire about age of pregnancy. Explain risk/benefits, only consider COVID-19 immunization for pregnant women with ≥ 13 weeks of pregnancy when potential benefits are greater than any potential risks for mothers and children.

- Pregnant women (if any) or breastfeeding women: check with the instructions for use of the vaccine to indicate the type of vaccine permitted for use.

2. Clinical evaluation

2.1. Detect any irregularity in vital signs:

- Measure body temperature of everyone arrives for immunization.

- Measure blood pressure of individuals having history of hypertension/hypotension, individuals having underlying medical conditions related to cardiovascular diseases, and individuals older than 65 years of age.

- Measure pulse, count respiratory rate of individuals having history of heart failure or having any irregularity such as chest pain, dyspnea, etc.

2.2. Observe general appearance

- Assess level of senses by asking questions about the individuals arriving for immunization. Pay attention to individuals having severe underlying medical conditions that cause them to be bed ridden, lose senses, or lose behavioral capacity.

- Record any visual irregular symptoms in individuals arriving for vaccination in order to inquire about health record.

IV. Screening conclusion

- Recommend immunization for cases eligible for immunization.

- Delay immunization for cases where at least one factor demanding delay of immunization is present.

- Transfer to medical facilities capable of providing emergency care for allergic shock for cases with history of level 3 allergic shock regardless of causes.

- Pregnant women with ≥ 13 weeks of pregnancy after receiving explanation regarding risks/benefits and agreeing to be vaccinated should be transported for immunization in medical facilities capable of providing medical care in obstetrics.

- Do not recommend immunization for individuals who have contraindications for immunization.

V. Implementation

1. Screening personnel

Screening personnel must receive training regarding COVID-19 immunization screening and dealing with allergic shock as per Circular No. 51/2017/TT-BYT of Ministry of Health.

2. Equipment

- Thermometer, stethoscope, blood pressure meter.

- COVID-19 immunization screening schedule (attached under Annex).

- Medicine box for allergic shock and essential medical equipment for responding to allergic shock according to Annex V of Circular no. 51/2017/TT-BYT of Minister of Health.

- Prepare 1 Adrenaline 1 mg/1 ml syringe.

3. Recording of screening and documents

- Immunization beneficiaries shall receive physical examination, be advised, and sign immunization commitment.

- Record and store immunization data of beneficiaries, including cases of contraindications on software for managing population health record on http//hssk.kcb.vn as per applicable laws.

- Immunization screening form and immunization commitment shall be stored in immunization entities. Storage period shall be 15 days.

Other contents require compliance with immunization guidelines of Ministry of Health./.

APPENDIX

 (Attached to Decision No. 5785/QD-BYT dated December 21, 2021)

COVID-19 IMMUNIZATION SCREENING FORM FOR PEOPLE AGED 18 OR MORE

Full name: ..................................................   Date of birth:      /............ /........... Male □ Female □

Citizen identity card/Passport (if any):......................................... No……Phone number:…………………

Address: ....................................................................................................................

Received COVID-19 vaccine:

□ Not receive yet

□ Received the 1st dose, type of vaccine: ………………..………… Date of immunization:.................................

□ Received the 2nd dose, type of vaccine: ………………..………… Date of immunization:.................................

□ Received the 3rd dose, type of vaccine: ………………..………… Date of immunization:.................................

I. Screening

II. Conclusion:

- Eligible for immediate immunization: NO irregularity and NO contraindication against the vaccine in the instructions for use of the manufacturer

- Contraindication against the same vaccine: In case of ANY irregularity in section 1            □

- Delayed immunization: In case of ANY irregularity under sections 2, 3a         □

- Immunization provided by medical facilities eligible for providing medical care for allergic shock: In case of ANY irregularity in section 4            □

- Caution in vaccination: In case of ANY irregularity under sections 3b, 5, 6, 7, 8, 9         □

Reason: .........................................................................................................................

^{______________________________________}

^a Pregnant women (if any) or breastfeeding women: check with the instructions for use of the vaccine to indicate the type of vaccine permitted for use.

^b For pregnant women with ≥ 13 weeks of pregnancy: Explain risk/benefits, require COVID-19 immunization commitment, and transfer to medical facilities providing obstetric care for vaccination.

^c Measure pulse, count respiratory rate of individuals having history of heart failure or having any irregularity such as chest pain, dyspnea, etc.

^d Measure blood pressure of individuals having history of hypertension/hypotension, individuals having underlying medical conditions related to cardiovascular diseases, and individuals older than 65 years of age.

^e Contraindication or delayed immunization as recommended by the manufacturer against the vaccine or any irregularity